Vaccinations with the AstraZeneca corona vaccine will continue in Finland on Monday.
However, as a precautionary measure, the vaccine is not currently given to people under 65 years of age due to suspected side effects.
In Finland, the other Nordic countries and Germany, some rare cases of very rare cerebral venous thrombosis and so-called generalized intravenous coagulation have been reported in vaccinees under the age of 65, THL is told me. Their possible association with AstraZeneca’s coronary vaccine is being investigated. No similar symptoms have been reported in vaccinated patients over 65 years of age.
Chief Physician of the Department of Health and Welfare (THL) Hanna Nohynek said on Friday that it is not yet possible to answer the question of whether people under the age of 65 who received one AstraZeneca vaccine will receive another peak of the same vaccine.
– Fortunately, there is still time for 12 weeks after the first vaccination of those who have received one AstraZeneca vaccine (when the second vaccination should be given). Of course, we hope that those who received one spike could continue to be vaccinated with the same vaccine. However, we want to make sure that the evidence for the safety of the vaccine supports this decision, Nohynek told STT.
According to Nohynek, AstraZeneca has vaccinated about 180,000 people in Finland. An estimated 118,000 of them, or about two-thirds, are under the age of 65.
Source site www.is.fi